TRACON Pharmaceutical (TCON) Tops Q2 EPS by 13c
Tweet
Share
E-mailGet Alerts TCON Hot Sheet
Join SI Premium – FREE
TRACON Pharmaceutical (NASDAQ: TCON) reported Q2 EPS of ($0.20), $0.13 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $9 million.
For earnings history and earnings-related data on TRACON Pharmaceutical (TCON) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
